Solanbridge Group Stock Today
Performance0 of 100
| Odds Of DistressOver 86
|
Solanbridge has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Solanbridge Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of September 2024 and ending today, the 11th of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. The company was founded in 2000 and is headquartered in The Woodlands, Texas. SOLANBRIDGE GROUP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.. The company has 2.61 B outstanding shares. More on Solanbridge Group
Moving together with Solanbridge Stock
Moving against Solanbridge Stock
Solanbridge Group cannot be verified against its exchange. Apparently, Solanbridge is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshSolanbridge Stock Highlights
| CEO, Director | Charles Shirley | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Solanbridge Group (SLNX) is traded on OTCCE Exchange in USA and employs 4 people. Solanbridge is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 52.21 K. Solanbridge Group conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 2.61 B outstanding shares.
Solanbridge generates negative cash flow from operations
Check Solanbridge Probability Of Bankruptcy
Solanbridge Stock Against Markets
Try Other Suggestions
Additional Tools for Solanbridge Stock Analysis
When running Solanbridge's price analysis, check to measure Solanbridge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solanbridge is operating at the current time. Most of Solanbridge's value examination focuses on studying past and present price action to predict the probability of Solanbridge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solanbridge's price. Additionally, you may evaluate how the addition of Solanbridge to your portfolios can decrease your overall portfolio volatility.